维普中文期刊产品整合服务
20篇 您的检索式:作者名="Linazasoro"
    题名 作者 年代 出处 被引量
1Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off:a randomised,double-blind trial显示文摘Tolosa E Hernández B Linazasoro G 2013Neural Transm2013,10,107:1
2Controlled release levodopa m Parkinson' s disease: influence of selection criteria and conversion recommendations in the clinical outcome of 450 patients 显示文摘Linazasoro G Grandas F Martinez Martin P et 71 1999ClinNeuropharmacol1999,22,2:1
3Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease显示文摘Linazasoro G Van Blercom N Lasa A 0,,06:1
4New ideas on the origin of L-dopa-indueed dyskinesias: age, genes and neural plasticity 显示文摘Linazasoro G 2005Trends Pharmacol Sci2005,26,8:1
5Classical Parkinson disease versus Parkinson complexreflections against staging and in favour of heterogeneity 显示文摘Linazasoro G 2007Eur J Neurol2007,14,:1
6Classifying risk factors for dyskinesia in Parkinson's disease显示文摘Sharma JC Bachmann CG Linazasoro G 2010Parkinsonism Relat Disord2010,16,8:1
7Levodopa-induced dyskinesias in Parkinson disease are independent of the extent of striatal dopaminergic denervation:a pharmacological and SPECT stody显示文摘Linazasoro G Van Biercom N Bergaretxe A 2009Clin Neuropharmacol2009,32,6:1
8Should levodopa dose be reduced when switched to stalevo?显示文摘LINAZASORO G KULISEVSKY J HERNANDEZ B 2008Eur J Neurol2008,15,3:1
9Neuroprotection in Parkinson's disease:love story or mission impossible显示文摘Linazasoro G 2002Expert Rev Neurotherap2002,2,:1
10Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopaentacapone combination显示文摘Castro A Valldeoriola F Linazasoro G 2005Neurologia2005,20,:1
11Optimization of use of levodopa in Parkinson's disease:role of levodopa-carbidopaentacapone combination显示文摘Castro A Valldeoriola F Linazasoro G 2005Neurologia2005,20,:1
12Efficacy and tolerance of gabapentin in dystonia and hemifacial spasm: a pilot study显示文摘Linazasoro Cristobal G 2001Rev Neurol2001,33,5:1
13Classical parkinson disease versus parkinson complexreflections against staging and in favour of heterogeneity 显示文摘Linazasoro G 2007Eur J Neurol2007,14,7:1
14Should levodopa dose be reduced when switched to stalevo?显示文摘LINAZASORO G KULISEVSKY J HERNANDEZ B 2008Eur J Neurol2008,15,3:1
15Nocturnalak athisia in Parkinson's disease: treatment with clozapine 显示文摘Linazasoro G Marti Masso JF Suarez JA 1993Mov Disord1993,8,:1
16显示文摘Obeso JA Linazasoro G Guridi J 2000J Neurol Neurosurg Psychiatry2000,68,1:1
17Classical parkinson disease versus parkinson com- plex - reflections against staging and in favour of heterogeneity 显示文摘Linazasoro G 2007Eur J Neurol2007,14,7:1
18Imaging 13-amyloid burden in aging and dementia显示文摘Linazasoro G 2008Neurology2008,70,18:1
19Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease:an in vivo study by PET显示文摘Linazasoro G Obeso JA Gomez JC 1999Clin Neuropharmacol1999,22,5:1
20New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity, Trends显示文摘Linazasoro G 2005Pharma- col Sci2005,26,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费